Tharimmune logo

Tharimmune Share Price (NASDAQ: THAR)

$4.68

-0.29

(-5.84%)

Last updated on

Check the interactive Tharimmune Stock chart to analyse performance

Tharimmune stock performance

as on August 23, 2025 at 1:29 AM IST

  • Today's Low:$4.36
    Today's High:$5.30

    Day's Volatility :17.74%

  • 52 Weeks Low:$0.95
    52 Weeks High:$6.39

    52 Weeks Volatility :85.1%

Tharimmune Stock Returns

PeriodTharimmune IncIndex (Russel 2000)
3 Months
226.92%
0.0%
6 Months
176.63%
0.0%
1 Year
63.46%
0.0%
3 Years
-94.34%
-7.8%

Tharimmune Inc Key Stats

Check Tharimmune key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$4.97
Open
$4.49
Today's High
$5.3
Today's Low
$4.36
Market Capitalization
$26.2M
Today's Volume
$12.7M
52 Week High
$6.39
52 Week Low
$0.952
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-6.06
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-340.26%

Stock Returns calculator for Tharimmune Stock including INR - Dollar returns

The Tharimmune stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tharimmune investment value today

Current value as on today

₹1,67,952

Returns

₹67,952

(+67.95%)

Returns from Tharimmune Stock

₹63,636 (+63.64%)

Dollar Returns*

₹4,316 (+4.32%)

Indian investors sentiment towards Tharimmune Stock

22100.0%

Period: Jul 23, 2025 to Aug 22, 2025. Change in 30 Days versus previous period

Investment in Tharimmune Shares from India has grown by 22100.0% over the past 30 days, indicating increased transactional activity.

2100%

Period: Jul 23, 2025 to Aug 22, 2025. Change in 30 Days versus previous period

Search interest for Tharimmune Stock from India on INDmoney has increased by 2100% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Tharimmune Stock

Rating
Trend

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Tharimmune(by analysts ranked 0 to 5 stars)

Tharimmune Share Price Target

What analysts predicted

Upside of 6.84%

Target:

$5.00

Current:

$4.68

Tharimmune share price target is $5.00, a slight Upside of 6.84% compared to current price of $4.68 as per analysts' prediction.

Tharimmune Stock Insights

  • Price Movement

    In the last 7 days, THAR stock has moved up by 246.3%
  • THAR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.6% return, outperforming this stock by 3.1%

Tharimmune Technicals Summary

Sell

Neutral

Buy

Tharimmune is currently in a neutral trading position according to technical analysis indicators.

Tharimmune Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Tharimmune Inc logo
205.56%
176.63%
63.46%
-94.34%
-94.34%
Regeneron Pharmaceuticals, Inc. logo
4.38%
-17.37%
-50.85%
-2.23%
-0.91%
Beone Medicines Ltd logo
5.81%
21.35%
61.84%
78.01%
32.14%
Vertex Pharmaceuticals Incorporated logo
-16.34%
-17.97%
-17.9%
35.76%
47.74%
Alnylam Pharmaceuticals, Inc. logo
38.5%
82.49%
66.63%
105.56%
244.81%

About Tharimmune Inc

Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic conditions with high unmet need in the United States. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH023 which is phase 1 clinical trial used to treat multiple high value autoimmune indications; and HS1940, which targets programmed cell death protein 1 (PD-1). It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is headquartered in Bridgewater, New Jersey.
Organization
Tharimmune
Employees
2
CEO
Mr. Sireesh Appajosyula Pharm.D.
Industry
Miscellaneous

Key Management of Tharimmune Inc

NameTitle
Mr. Sireesh Appajosyula Pharm.D.
CEO & Director
Mr. Vincent LoPriore
Executive Chairman of the Board
Mr. Dong Kim
Chief Financial Officer

Important FAQs about investing in THAR Stock from India :

What is Tharimmune share price today?

Tharimmune share price today is $4.68 as on at the close of the market. Tharimmune share today touched a day high of $5.30 and a low of $4.36.

What is the 52 week high and 52 week low for Tharimmune share?

Tharimmune share touched a 52 week high of $6.39 and a 52 week low of $0.95. Tharimmune stock price today i.e. is closed at $4.68, lower by 26.76% versus the 52 week high.

How to invest in Tharimmune Stock (THAR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tharimmune on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tharimmune Shares that will get you 0.3205 shares as per Tharimmune share price of $4.68 per share as on August 23, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Tharimmune Stock (THAR) from India?

Indian investors can start investing in Tharimmune (THAR) shares with as little as ₹87.521 or $1 (as of August 23, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Tharimmune stock (as per the Rupee-Dollar exchange rate as on August 23, 2025). Based on Tharimmune share’s latest price of $4.68 as on August 23, 2025 at 1:29 AM IST, you will get 2.1368 shares of Tharimmune. Learn more about fractional shares .

What are the returns that Tharimmune has given to Indian investors in the last 5 years?

Tharimmune stock has given -94.34% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?